Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study.

Fuereder T, Wacheck V, Strommer S, Horak P, Gerschpacher M, Lamm W, Kivaranovic D, Krainer M.

PLoS One. 2014 Apr 22;9(4):e95310. doi: 10.1371/journal.pone.0095310. eCollection 2014.

PMID:
24755958
[PubMed - in process]
Free PMC Article
2.

Targeted therapies for bone sarcomas.

Heymann D, RĂ©dini F.

Bonekey Rep. 2013 Jul 17;2:378. doi: 10.1038/bonekey.2013.112.

PMID:
24422100
[PubMed]
Free PMC Article
3.

Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.

Glade Bender JL, Lee A, Reid JM, Baruchel S, Roberts T, Voss SD, Wu B, Ahern CH, Ingle AM, Harris P, Weigel BJ, Blaney SM.

J Clin Oncol. 2013 Aug 20;31(24):3034-43. doi: 10.1200/JCO.2012.47.0914. Epub 2013 Jul 15.

PMID:
23857966
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma.

Sampson VB, Gorlick R, Kamara D, Anders Kolb E.

Front Oncol. 2013 May 31;3:132. doi: 10.3389/fonc.2013.00132. eCollection 2013.

PMID:
23755370
[PubMed]
Free PMC Article
5.

The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.

Dasgupta T, Haas-Kogan DA.

Front Oncol. 2013 May 10;3:110. doi: 10.3389/fonc.2013.00110. eCollection 2013.

PMID:
23717811
[PubMed]
Free PMC Article
6.

Bone sarcomas: from biology to targeted therapies.

Gaspar N, Di Giannatale A, Geoerger B, Redini F, Corradini N, Enz-Werle N, Tirode F, Marec-Berard P, Gentet JC, Laurence V, Piperno-Neumann S, Oberlin O, Brugieres L.

Sarcoma. 2012;2012:301975. doi: 10.1155/2012/301975. Epub 2012 Nov 27.

PMID:
23226965
[PubMed]
Free PMC Article
7.

Ontogeny and sorafenib metabolism.

Zimmerman EI, Roberts JL, Li L, Finkelstein D, Gibson A, Chaudhry AS, Schuetz EG, Rubnitz JE, Inaba H, Baker SD.

Clin Cancer Res. 2012 Oct 15;18(20):5788-95. doi: 10.1158/1078-0432.CCR-12-1967. Epub 2012 Aug 27.

PMID:
22927483
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions.

Chandhanayingyong C, Kim Y, Staples JR, Hahn C, Lee FY.

Sarcoma. 2012;2012:404810. doi: 10.1155/2012/404810. Epub 2012 Apr 12.

PMID:
22577336
[PubMed]
Free PMC Article
9.

Neurotoxicity of biologically targeted agents in pediatric cancer trials.

Wells EM, Nageswara Rao AA, Scafidi J, Packer RJ.

Pediatr Neurol. 2012 Apr;46(4):212-21. doi: 10.1016/j.pediatrneurol.2012.02.006. Review.

PMID:
22490765
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.

DuBois SG, Shusterman S, Reid JM, Ingle AM, Ahern CH, Baruchel S, Glade-Bender J, Ivy P, Adamson PC, Blaney SM.

Cancer Chemother Pharmacol. 2012 Apr;69(4):1021-7. doi: 10.1007/s00280-011-1798-2. Epub 2011 Dec 18.

PMID:
22179104
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

Glade Bender J, Yamashiro DJ, Fox E.

Oncologist. 2011;16(11):1614-25. doi: 10.1634/theoncologist.2011-0148. Epub 2011 Oct 31. Review.

PMID:
22042784
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk